UHC is the cornerstone of global health equity and sustainable development. However, 50% of the world’s population do not have access to the essential health services, indicating that major efforts will be required to overcome this critical gap.

The Covid-19 pandemic has amplified the need for ready and resilient health systems that ensure health for all. The second UN High-level Meeting on UHC scheduled September 2023 sets a global stage to discuss opportunities and challenges for UHC.

IFPMA is committed to progress toward UHC and seeks to leverage innovation to achieve health equity, emphasizing three foundational elements:  improving primary health care, ensuring adequate financing, and focusing on multistakeholder partnerships. Read our position paper on UHC.

The innovative pharmaceutical industry plays a key role toward achieving UHC.

As a key member of the UHC2030 Private Sector Constituency (PSC), IFPMA is strongly supportive of the recent UHC2030 Private Sector Constituency statement on private sector commitments drawing from the Action Agenda. The Action Agenda is a set of action-oriented policy recommendations aimed at country leaders to strengthen resilient and equitable health systems, advance universal health coverage and health security, and deliver health for all by 2030.

The UHC2030 PSC statement outlined five commitments:

1. Incorporate UHC principles, including to leave no one behind, into our business
2. Deliver innovations that respond to the needs of all people including underserved populations, and make these safe, affordable, accessible, and sustainable
3. Help strengthen the health workforce, responding to local context, priorities and needs
4. Contribute to efforts to raise the finance available for UHC
5. Champion and engage in multi-stakeholder policy dialogues that advance UHC.